Clinical trial
Safety Study of a Refrigerator-stable Formulation of VARIVAX®
NCT00432731 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00432731 |
|---|---|
| Title | Safety Study of a Refrigerator-stable Formulation of VARIVAX® |
| Official title | A Double-blind, Randomised, Controlled, Multi-centre Safety Study of a Refrigerator-stable Formulation of VARIVAX® in Healthy 12 to 15 Month-old Infants. |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Varicella, Measles, Mumps, Rubella |
| Intervention type | Biological |
| Interventions | VARIVAX®, M-M-RTM II |
| Enrollment | 500 |
| Start date | Dec 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Feb 8, 2007 |
| Last update posted | Mar 14, 2017 |
| Countries | France, Italy |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: